General

Irish Pharmaceutical Stability Storage Company says there won’t be capacity storage issues for COVID Vaccine

Recognising that the Pfizer BioNTech Covid-19 vaccine will need to be stored at subzero temperatures along with distribution challenges in rolling it out across Ireland, Waterford based Q1 Scientific a global leader in Stability Storage says that it already stores and distributes medical drugs at this level and are ready to provide their services to store and distribute the anticipated COVID19 vaccine.

Stephen Delaney CEO at Q1 Scientific

Recognising that the Pfizer BioNTech Covid-19 vaccine will need to be stored at subzero temperatures along with distribution challenges in rolling it out across Ireland, Waterford based Q1 Scientific a global leader in Stability Storage says that it already stores and distributes medical drugs at this level and are ready to provide their services to store and distribute the anticipated COVID19 vaccine.

CEO of Q1 Scientific Stephen Delaney spoke of the challenges around the storage and distribution of the COVID19 vaccine on the latest ‘The Science of Business’ podcast, which was released today (November 30th 2020). Stephen says, “Cold chain distribution in pharma is complicated even in normal times and right now Ireland will need to make available its cold chain capacity to accommodate deliveries of the COVID19 vaccine, however, if public services and the private sector all come together there won’t be capacity storage issues within Ireland.”

For verified healthcare professionals

Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.

Register for free Log in

Join the conversation

Comments are open to registered members. Log in or register to share your thoughts on this article.

Log in to comment Register for free